Jostein Davidsen

Acino International AG develops and manufactures pharmaceuticals in novel drug delivery form. The firm provides drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. It offers abelcet, bactiflox, clopacin, dolonica, hydronica, neurorubine, olfen and spasfon. The company was founded in 1836 and is headquartered in Zurich, Switzerland.

Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark.

Labatec Pharma SA engages in the provision of pharmaceutical business. Its products include injectable and orals for hospital use, specialty retail prescription, and over-the-counter products and supplements. The company was founded in 1957 and is headquartered in.

Primex Pharmaceuticals Oy manufactures and markets healthcare products. The fims's products include Dobuject and Recofol N. It also produces several other products for anesthesia and intensive care. The company was founded by Mikko Laiho, Pekka Leinonen, Janne Kovalainen, Kari Sarvanto and Jany Mengelkamp in 2008 and is headquartered in Helsinki, Finland.

Primex Pharmaceuticals AG operates as a pharmaceutical company which develops, manufactures, and markets healthcare products and medicines to consumers and healthcare professionals. The company was founded by Kari Sarvanto in 2008 and is headquartered in Zug, Switzerland.